Clinical Trial Update: Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO] [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating lesional changes in high-risk patients with neoatherosclerosis treated with rosuvastatin and EPA, assessed by optical coherenc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Kobe University | Conditions: Coronary Artery Disease, Angina Pectoris | Phase 4 | Status: UNKNOWN